Status:
COMPLETED
Actigraphic Analysis of Treatment Response
Lead Sponsor:
Child Psychopharmacology Institute
Conditions:
Sleep Disorders, Circadian Rhythm
Insomnia
Eligibility:
FEMALE
2-10 years
Phase:
NA
Brief Summary
The study examines and illustrates the utility of utilizing actigraphic measurements to assess treatment response.
Detailed Description
Actigraphic measurements will be recorded every 30 seconds and will be recorded for an 11 day baseline period, followed by a 10 day period of the initial pharmacological interventions. The non-invasiv...
Eligibility Criteria
Inclusion
- Diagnosis of Kabuki Syndrome
- Medication Naive
- Single subject preparing to receive pharmacological intervention
Exclusion
- Inability to wear actigraphy device
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00723580
Start Date
May 1 2008
End Date
August 1 2010
Last Update
August 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Child Psychopharmacology Institute
Fargo, North Dakota, United States, 58103